Cancer Chemother Pharmacol
Antineoplastic AgentsDrug MonitoringGlycine
Dr. Samuel Agresta, MD
NPI1043251457
- Publications
- 11
- Clinical trials
- 5
- State license
- 1
- Year NPI issued
- 2006
- Practice address
- 12902 Magnolia Dr, Tampa, FL 33612-9416
- Practice phone
- Call (813) 745-5768
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Agresta's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Samuel Agresta is an internist in Tampa, Florida
Dr. Agresta practices in Tampa, Florida.
Dr. Agresta's NPI, 1043251457, was assigned on June 9, 2006. Dr. Agresta graduated from Tulane School of Medicine in 1999. Dr. Agresta's Florida license number on file is ME96014.
NPI and contact details
- NPI
- 1043251457NPI Registry (opens in a new tab)
- NPI enumeration date
- June 9, 2006
- NPI status
- Active
- Practice phone
- (813) 745-5768
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Samuel Agresta's practice address is in Tampa, Florida
Dr. Agresta's practice address in the NPI Registry is 12902 Magnolia Dr, Tampa, FL 33612-9416. The practice phone is (813) 745-5768.
- NPI Registry address12902 Magnolia Dr, Tampa, FL 33612-9416Phone(813) 745-5768
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Samuel Agresta's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agresta practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Agresta's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Agresta practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Samuel Agresta is one of 9,009 internists in Florida
Internal medicine is Dr. Agresta's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Agresta has a license on file in Florida.
Specialties and state licenses
- Internal medicine, FloridaPrimary
Internists near Dr. Agresta
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Samuel Agresta has 11 publications on record
Dmand AI links 11 papers to Dr. Agresta, published from 2011 to 2020. 2019 was the busiest year, with 3. The most frequent topics are Isocitrate Dehydrogenase, Leukemia, Myeloid, Acute and Antineoplastic Agents. Dr. Agresta has published most often in Cancer Control. Dr. Agresta's most frequent co-authors are Courtney Denton Dinardo, MD, Eytan Moshe Stein, MD and Gina Z. D'Amato, MD.
Papers11
Years published2011 to 2020
Dr. Agresta's papers by year, 2011 to 2020
Topics Dr. Agresta writes about most
- Isocitrate Dehydrogenase
- Leukemia, Myeloid, Acute
- Antineoplastic Agents
- Glycine
- Pyridines
- Maximum Tolerated Dose
- Remission Induction
Dr. Agresta's most frequent co-authors
- Courtney Denton Dinardo, MD4 shared papers
- Eytan Moshe Stein, MD3 shared papers
- Gina Z. D'Amato, MD2 shared papers
Recent publications by Dr. Agresta
Lancet Gastroenterol Hepatol
Antineoplastic AgentsBile Duct NeoplasmsCholangiocarcinoma
Eur J Clin Pharmacol
Administration, OralAntineoplastic AgentsArea Under Curve
AminopyridinesEnzyme InhibitorsHematologic Diseases
J Inherit Metab Dis
Brain Diseases, Metabolic, InbornCardiomyopathiesDisease Models, Animal
See who Dr. Agresta researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Agresta works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Samuel Agresta has worked on 5 clinical trials
Dmand AI links Dr. Agresta to 5 clinical trials, 3 of them phase 1 studies. Conditions studied include Carcinoma, Transitional Cell, Triple Negative Breast Neoplasms and Carcinoma, Renal Cell. Agios Pharmaceuticals, Inc. sponsors the most, 3.
Clinical trials with Dr. Agresta by phase
- 3Phase 1: 3 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Agresta's trials
- Carcinoma, Transitional Cell
- Triple Negative Breast Neoplasms
- Carcinoma, Renal Cell
- Urinary Bladder Neoplasms
Recent clinical trials with Dr. Agresta
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma (opens in a new tab)
Status unknownPhase 2
Triple Negative Breast NeoplasmsCarcinoma, Renal CellAtezolizumabBevacizumabIPI-549 (eganelisib)
Carcinoma, Transitional CellUrinary Bladder NeoplasmsNivolumabIPI-549 (eganelisib)
AG221
AG-348
AG-348
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Samuel Agresta graduated from Tulane School of Medicine
Dr. Agresta graduated from Tulane School of Medicine in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Samuel Agresta's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Samuel Agresta
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Samuel Agresta's NPI number?
Dr. Samuel Agresta's NPI number is 1043251457. It was assigned on June 9, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Samuel Agresta?
Dr. Samuel Agresta is an internist in Tampa, Florida. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Samuel Agresta practice?
Dr. Agresta practices at 12902 Magnolia Dr, Tampa, FL 33612-9416.
What is Dr. Samuel Agresta's office phone number?
The practice phone on file for Dr. Agresta is (813) 745-5768.
What is Dr. Samuel Agresta's medical license number?
Dr. Agresta's Florida license number on file is ME96014.
Where did Dr. Samuel Agresta go to medical school?
Dr. Agresta graduated from Tulane School of Medicine in 1999.
How long has Dr. Samuel Agresta been practicing?
Dr. Agresta graduated from medical school in 1999, 27 years ago.
Does Dr. Samuel Agresta do research?
Dmand AI links 11 publications to Dr. Agresta, published from 2011 to 2020. Dr. Agresta has worked on 5 clinical trials.
Who does Dr. Samuel Agresta publish with?
Dr. Agresta's most frequent co-authors are Courtney Denton Dinardo, MD (4 shared papers), Eytan Moshe Stein, MD (3 shared papers) and Gina Z. D'Amato, MD (2 shared papers).
Selling to internal medicine practices?
See internists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card